Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

EphB4 controls blood vascular morphogenesis during postnatal angiogenesis.

Ralf Erber1, Uta Eichelsbacher, Violetta Powajbo

  • 1Department of Neurosurgery, Faculty for Clinical Medicine of the University of Heidelberg, University Hospital Mannheim, Mannheim, Germany.

The EMBO Journal
|January 21, 2006
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

AI-driven multi-omics drug repurposing nominates AZD7762 as a multitarget inhibitor of IL22RA1 and FAM221A in esophageal squamous cell carcinoma.

NPJ precision oncology·2026
Same author

Disrupting VE-cadherin Y685 phosphorylation inhibits development of experimental diabetic and prediabetic retinopathy.

The Journal of clinical investigation·2026
Same author

Causal association between modifiable risk factors and esophageal cancer: A Mendelian randomization study.

Discover oncology·2025
Same author

Correction: Zhang et al. TRANS-CNN-Based Gesture Recognition for mmWave Radar. <i>Sensors</i> 2024, <i>24</i>, 1800.

Sensors (Basel, Switzerland)·2025
Same author

Impact of Interval to Esophagectomy After Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: A Multicenter Retrospective Cohort Analysis.

Thoracic cancer·2025
Same author

Elucidating the role of CYFIP2 in conferring cisplatin resistance in esophageal squamous cell carcinoma.

Scientific reports·2024

Guidance molecules like EphB4 regulate blood vessel growth and network formation in tumors and other tissues. These molecules control vascular patterning during both development and postnatal angiogenesis.

Area of Science:

  • Molecular Biology
  • Developmental Biology
  • Cancer Research

Background:

  • Guidance molecules are known to regulate embryonic vascular patterning.
  • Their role in postnatal angiogenesis, particularly in tumors, remains largely unexplored.

Purpose of the Study:

  • To investigate the function of guidance molecules, specifically EphB4 and ephrinB2, in human malignant brain tumors.
  • To determine the role of EphB4 in postnatal angiogenesis in both neoplastic and non-neoplastic contexts.

Main Methods:

  • Overexpression of EphB4 variants in the blood vessels of tumor xenografts.
  • Analysis of vascular network formation, vessel branching, and vascular permeability.
  • Assessment in non-neoplastic cell grafts and retinal vascularization models.

Related Experiment Videos

Main Results:

  • EphB4 acts as a negative regulator of blood vessel branching and network formation, promoting circumferential growth over sprouting.
  • EphB4 reduces tumor vascular permeability by activating the angiopoietin-1/Tie2 pathway.
  • These functions were confirmed in non-neoplastic postnatal angiogenesis models.

Conclusions:

  • Guidance molecules, such as EphB4, play a critical role in vascular patterning during postnatal angiogenesis, not just embryonic development.
  • Both tumor and normal tissue vascularization are governed by vascular initiation and guidance molecule-mediated patterning programs.